1. Home
  2. JANX vs MPT Comparison

JANX vs MPT Comparison

Compare JANX & MPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

N/A

Current Price

$10.13

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Medical Properties Trust Inc. common stock

MPT

Medical Properties Trust Inc. common stock

N/A

Current Price

$1.82

Market Cap

983.5M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
JANX
MPT
Founded
2017
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
983.5M
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
JANX
MPT
Price
$10.13
$1.82
Analyst Decision
Buy
Hold
Analyst Count
18
7
Target Price
★ $33.14
$3.55
AVG Volume (30 Days)
946.4K
★ 23.6M
Earning Date
11-05-2026
10-29-2026
Dividend Yield
N/A
★ 21.95%
EPS Growth
N/A
★ 88.56
EPS
N/A
★ 0.05
Revenue
$10,000,000.00
★ $972,022,000.00
Revenue This Year
$174.21
N/A
Revenue Next Year
N/A
$4.41
P/E Ratio
★ N/A
$32.80
Revenue Growth
N/A
★ N/A
52 Week Low
$10.16
$1.48
52 Week High
$35.34
$6.47

Technical Indicators

Market Signals
Indicator
JANX
MPT
Relative Strength Index (RSI) 25.34 34.74
Support Level N/A N/A
Resistance Level $14.47 $5.32
Average True Range (ATR) 1.16 0.16
MACD -0.48 0.03
Stochastic Oscillator 0.33 48.59

Price Performance

Historical Comparison
JANX
MPT

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

About MPT Medical Properties Trust Inc. common stock

Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. Its business strategy is to acquire and develop healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases, which require the tenant to bear of the costs associated with the property. The group's geographic areas are the United States, the United Kingdom, and All other countries.

Share on Social Networks: